국내 간암의 역학 = Epidemiology of liver cancer in Korea

다국어 초록 (Multilingual Abstract)

The incidence rate of primary liver cancer in Korea, the majority of which is hepatocellular carcinoma, has been decreasing steadily since 1999. However, Korea still has one of the highest incidence rates of liver cancer worldwide. Currently, liver cancer is the fifth most common cancer type in men and sixth in women. A total of 15,771 cases (11,774 men and 3,997 women) were identified, with an age-standardized incidence rate of 18.0 persons per 100,000 (29.2 in men and 7.9 in women) in 2016. Mortality from liver cancer has also decreased since 2002 in both sexes, although it is still the second most common cause of cancer deaths with 10,721 deaths (7,982 in men and 2,739 in women) in 2017. The 5-year relative survival rate was 13.2% in those diagnosed in 1996-2000, and it increased to 34.3% in those diagnosed in 2012-2016. Hepatitis B (HBV) and C (HCV) viruses are the most important causes of liver cancer, accounting for approximately 70% and 10% of liver cancer cases, respectively. Recently, the seroprevalence of HBV has markedly decreased to less than 3%, and the HCV antibody positivity rate has been estimated as about 0.7% in a nationwide survey. The participation rate of patients with hepatitis in liver cancer screening, a part of the National Cancer Screening Program, was still low at about 60% in 2018. Recent advances in the treatment of HBV and HCV could further reduce the burden of liver cancer despite its limited accessibility.

참고문헌 (Reference)

1 김도영, "진행성 간세포암종의 새로운 전신 치료제" 대한소화기학회 73 (73): 10-15, 2019

2 권순석, "Updates on cancer epidemiology in Korea, 2018" 의과학연구소 54 (54): 90-100, 2018

3 서미나, "Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012" 대한암학회 49 (49): 798-806, 2017

4 Korea Centers for Disease Control and Prevention, "The Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII)" Korea Centers for Dis-ease Control and Prevention 2018

5 Kim BH, "Temporal improvement in survival of patients with hepatocellular carcinoma in a hepatitis B virus-endemic population" 33 : 475-483, 2018

6 Yoon SK, "Status of hepatocellular carcinoma in South Korea" 2 : 39-, 2013

7 Ahn HR, "Socioeconomic diffe-rences in self-and family awareness of viral hepatitis status among carriers of hepatitis B or C in rural Korea" 46 : 328-332, 2018

8 Noone AM, "SEER Cancer Statistics Review, 1975-2015" National Cancer Institute 2018

9 Kanwal F, "Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease" 155 : 1828-1837, 2018

10 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2019" 대한암학회 51 (51): 431-437, 2019

11 Corrao G, "Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis" 27 : 914-919, 1998

12 Choi J, "Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population" 66 : 1454-1463, 2017

13 Iida-Ueno A, "Hepatitis B virus infection and alcohol consumption" 23 : 2651-2659, 2017

14 Si Hyun Bae, "Hepatitis B Virus Genotype C Prevails Among Chronic Carriers of the Virus in Korea" 대한의학회 20 (20): 816-820, 2005

15 Su TH, "HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy : is HCC prevented or delayed" 67 : 1634-1635, 2018

16 World Health Organization, "Guidelines for the prevention, care and treatment of persons living with chronic hepatitis B infection"

17 McGlynn KA, "Global epidemiology of hepatocellular carcinoma : an emphasis on demographic and regional variability" 19 : 223-238, 2015

18 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018

19 Shin A, "Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea" 18 : 1894-1898, 2009

20 Cho EJ, "Current status and strategies for hepatitis B control in Korea" 23 : 205-211, 2017

21 Lee D, "Cost-effectiveness of antiviral pro-phylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea" 16 : 6-, 2018

22 Broggio J, "Cancer survival in England: national estimates for patients followed up to 2017" Office for National Statistics 2019

23 Zeng H, "Cancer survival in China, 2003-2005 : a population-based study" 136 : 1921-1930, 2015

24 Foundation for Promotion of Cancer Research, "Cancer statis-tics in Japan 2018"

25 Canadian Cancer Statistics Advisory Committee, "Canadian cancer statistics 2018" Canadian Cancer Society 2018

26 정낙소, "B형 간염바이러스, 음주, 그리고 B형 간염바이러스와 음주의 중복 원인에 의한 간경변증에서 간세포암종 발생에 관한 단면 비교연구" 대한소화기학회 49 (49): 369-375, 2007

27 Statistics Korea, "Annual report on the causes of death statistics 2017" Statistics Korea 2018

28 National Cancer Center, "Annual report of cancer statistics in Korea in 2016" National Cancer Center 2018